Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-08 9:37 pm Purchase | 13D | TRAWS PHARMA, INC. TRAW | Viriom Inc. | 2,934,525 11.6% | 2,934,525 (New Position) | View |
| 2022-02-14 3:20 pm Sale | 13G | TRAWS PHARMA, INC. TRAW | CVI Investments Inc. | 0 0% | -1,175,000 (Position Closed) | View |
| 2021-10-01 11:01 am Purchase | 13G | TRAWS PHARMA, INC. TRAW | CVI Investments Inc. | 1,175,000 5.7% | 1,175,000 (New Position) | View |
| 2021-01-08 4:38 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | Lincoln Park Capital Fund LLC | 13,639,411 6.52% | 13,639,411 (New Position) | View |
| 2021-01-08 10:06 am Sale | 13G | ONCONOVA THERAPEUTICS INC ONTX | SABBY MANAGEMENT LLC | 206,730 11% | -8,534,513 (-97.64%) | View |
| 2020-02-18 6:59 pm Sale | 13D | ONCONOVA THERAPEUTICS INC ONTX | 683 Capital Management LLC | 100,000 1% | -493,334 (-83.15%) | View |
| 2020-02-14 4:53 pm Sale | 13G | ONCONOVA THERAPEUTICS INC ONTX | Point72 Asset Management L.P. | 3,000,000 2.6% | -230,434 (-7.13%) | View |
| 2020-02-14 4:29 pm Sale | 13G | ONCONOVA THERAPEUTICS INC ONTX | TYNDALL CAPITAL PARTNERS L P | 26,042 0.1% | -472,999 (-94.78%) | View |
| 2020-02-14 2:03 pm Sale | 13G | ONCONOVA THERAPEUTICS INC ONTX | EcoR1 Capital LLC | 0 0% | -423,441 (Position Closed) | View |
| 2020-01-13 4:06 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | SABBY MANAGEMENT LLC | 8,741,243 11% | 8,458,099 (+2987.21%) | View |
| 2020-01-10 4:03 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | ARMISTICE CAPITAL LLC | 7,286,201 4.99% | 1,993,893 (+37.68%) | View |
| 2019-12-19 4:50 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | ARMISTICE CAPITAL LLC | 5,292,308 4.99% | 4,995,828 (+1685.05%) | View |
| 2019-12-02 5:12 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | INTRACOASTAL CAPITAL LLC | 2,066,559 4.99% | 2,066,559 (New Position) | View |
| 2019-11-26 5:24 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | Point72 Asset Management L.P. | 3,230,434 9.99% | 3,230,434 (New Position) | View |
| 2019-11-18 4:05 pm Sale | 13G | ONCONOVA THERAPEUTICS INC ONTX | TYNDALL CAPITAL PARTNERS L P | 499,041 6.1% | -343,273 (-40.75%) | View |
| 2019-09-27 3:52 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | SABBY MANAGEMENT LLC | 733,940 11% | 172,777 (+30.79%) | View |
| 2019-09-25 5:53 pm Sale | 13G | ONCONOVA THERAPEUTICS INC ONTX | ARMISTICE CAPITAL LLC | 430,536 4.99% | -1,176,964 (-73.22%) | View |
| 2019-09-20 3:20 pm Sale | 13D | ONCONOVA THERAPEUTICS INC ONTX | 683 Capital Management LLC | 593,334 9.7% | -15,909,835 (-96.40%) | View |